Correlation Between XBiotech and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both XBiotech and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XBiotech and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XBiotech and Milestone Pharmaceuticals, you can compare the effects of market volatilities on XBiotech and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XBiotech with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of XBiotech and Milestone Pharmaceuticals.
Diversification Opportunities for XBiotech and Milestone Pharmaceuticals
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between XBiotech and Milestone is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding XBiotech and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and XBiotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XBiotech are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of XBiotech i.e., XBiotech and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between XBiotech and Milestone Pharmaceuticals
Given the investment horizon of 90 days XBiotech is expected to generate 1.12 times less return on investment than Milestone Pharmaceuticals. In addition to that, XBiotech is 1.51 times more volatile than Milestone Pharmaceuticals. It trades about 0.12 of its total potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about 0.2 per unit of volatility. If you would invest 139.00 in Milestone Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 60.00 from holding Milestone Pharmaceuticals or generate 43.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
XBiotech vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| XBiotech |
| Milestone Pharmaceuticals |
XBiotech and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with XBiotech and Milestone Pharmaceuticals
The main advantage of trading using opposite XBiotech and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XBiotech position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| XBiotech vs. Seres Therapeutics | XBiotech vs. DiaMedica Therapeutics | XBiotech vs. Lyra Therapeutics | XBiotech vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |